共 82 条
- [1] Raghu G(2011)AN official ATS/ERS/JRS/ALAT statement: IPF evidence-based guidelines for diagnosis and treatment American Journal of Respiratory and Critical Care Medicine 183 788-824
- [2] Collard HR(2008)Abnormal wound healing responses in pulmonary fibrosis: focus on coagulation signalling European Respiratory Review 17 130-137
- [3] Egan JJ(2007)Cellular origin of pro-coagulant and antifibrinolytic factors in bleomycin-injured lungs European Respiratory Journal 29 1105-1114
- [4] Chambers RC(2008)Procoagulant signalling mechanisms in lung inflammation and fibrosis: new opportunities for pharmacological intervention? British Journal of Pharmacology 153 S367-S378
- [5] Wygrecka M(2008)Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases Thrombosis and Haemostasis 99 494-501
- [6] Markart P(2012)The roles of thrombin and protease-activated receptors in inflammation Seminars in Immunopathology 34 63-72
- [7] Ruppert C(2005)Anticoagulant therapy for idiopathic pulmonary fibrosis Chest 128 1475-1482
- [8] Chambers RC(2006)Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies Human Immunology 67 284-297
- [9] Wygrecka M(2009)Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury The Journal of Clinical Investigation 119 2550-2563
- [10] Jablonska E(2003)The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis American Journal of Clinical Pathology 203 556-567